30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Pharmaceuticals

HLS Therapeutics Inc (HLS)

Track

Over the last 90 days, HLS Therapeutics Inc. has seen net insider buying totaling $18,611.12, with two executives making purchases. This activity occurred against a backdrop of a 0.2% stock price decrease over the same period. The company's last earnings report showed a 41.67% beat.
Stock chart
Ticker: HLS Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Millian, Craig
Director of Issuer, Senior Officer of Issuer
1 purchase — total 100,000 USD
Buy 17 Jun 2026
Value US$3,703,623.84 | Price 120.58 | Shares 18,720
Buy 16 Jun 2026
Value CA$580,530.67 | Price 346.04 | Shares 85,477
Buy 18 Jun 2025
Value CA$495.00 | Price 4.95 | Shares 100
Buy 18 Jun 2025
Value CA$2,982.00 | Price 4.97 | Shares 600
Buy 31 Dec 2024
Value CA$165,783.12 | Price 3.93 | Shares 42,184
Buy 24 Dec 2024
Value CA$1,957.00 | Price 3.91 | Shares 500
Buy 12 Dec 2024
Value CA$6,825.00 | Price 3.25 | Shares 2,100
Sale 14 Nov 2024
Value CA$1,655.00 | Price 3.31 | Shares 500
Buy 14 Aug 2024
Value CA$3,828.00 | Price 3.19 | Shares 1,200
Buy 13 Aug 2024
Value CA$8,932.00 | Price 3.19 | Shares 2,800
Buy 15 May 2024
Value US$7,250.00 | Price 2.90 | Shares 2,500
Buy 15 Nov 2023
Value US$2,910.00 | Price 2.91 | Shares 1,000
Buy 13 Nov 2023
Value US$584.00 | Price 2.92 | Shares 200
Buy 10 Nov 2023
Value CA$8,876.88 | Price 3.70 | Shares 2,400
Buy 10 Nov 2023
Value CA$86,000.00 | Price 4.30 | Shares 20,000
Buy 9 Nov 2023
Value CA$43,600.00 | Price 4.36 | Shares 10,000
Buy 25 Aug 2023
Value CA$18,000.00 | Price 4.50 | Shares 4,000
Sale 30 Jun 2023
Value CA$7,507,500.00 | Price 5.78 | Shares 1,300,000
Buy 8 Jun 2023
Value CA$417,100.00 | Price 4.30 | Shares 97,000
Buy 19 May 2023
Value CA$11,250.00 | Price 4.50 | Shares 2,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-17 B Purchase
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
18,720 +17.2%
120.58
US$3,703,624 		18,720 +17.2% 120.58 US$3,703,624
2026-06-17 2026-06-16 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
85,477 +44.2%
346.04
CA$580,531 		85,477 +44.2% 346.04 CA$580,531
2025-06-19 2025-06-18 B Purchase
2.4
Edinboro, Dawn

Senior Officer of Issuer

Officer
61,810 +38.8%
378.11
CA$1,484,697 		61,810 +38.8% 378.11 CA$1,484,697
2025-06-19 2025-06-18 B Purchase
2.4
Edinboro, Dawn

Senior Officer of Issuer

Officer
600
4.97
CA$2,982 		600 4.97 CA$2,982
2025-01-08 2024-12-31 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
42,184 +42.6%
3.93
CA$165,783 		42,184 +42.6% 3.93 CA$165,783
2024-12-27 2024-12-24 B Purchase
1.5
Beauchamp, Norma

Director of Issuer

Non-Executive Director
500
3.91
CA$1,957 		500 3.91 CA$1,957
2024-12-16 2024-12-12 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
2,100 +2.2%
3.25
CA$6,825 		2,100 +2.2% 3.25 CA$6,825
2024-11-14 2024-11-14 S Sale
1.5
Beauchamp, Norma

Director of Issuer

Non-Executive Director
500
3.31
CA$1,655 		500 3.31 CA$1,655
2024-08-14 2024-08-14 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
1,200 +17.6%
3.19
CA$3,828 		1,200 +17.6% 3.19 CA$3,828
2024-08-14 2024-08-13 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
2,800 +70.0%
3.19
CA$8,932 		2,800 +70.0% 3.19 CA$8,932
2024-05-16 2024-05-15 B Purchase
Millian, Craig

Director of Issuer, Senior Officer of Issuer

Executive Director
2,500 +25.0%
2.90
US$7,250 		2,500 +25.0% 2.90 US$7,250
2023-11-15 2023-11-15 B Purchase
Walsh, Brian Thomas

Senior Officer of Issuer

Officer
1,000 +500.0%
2.91
US$2,910 		1,000 +500.0% 2.91 US$2,910
2023-11-15 2023-11-13 B Purchase
Walsh, Brian Thomas

Senior Officer of Issuer

Officer
200
2.92
US$584 		200 2.92 US$584
2023-11-14 2023-11-10 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
2,400 +0.0%
3.70
CA$8,877 		2,400 +0.0% 3.70 CA$8,877
2023-11-14 2023-11-10 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
20,000
4.30
CA$86,000 		20,000 4.30 CA$86,000
2023-11-14 2023-11-09 B Purchase
1.4
Polar Asset Management Partners Inc.

10% Security Holder of Issuer

Large shareholder
10,000 +0.2%
4.36
CA$43,600 		10,000 +0.2% 4.36 CA$43,600
2023-08-29 2023-08-25 B Purchase
2.6
Hanna, John Gordon

Director of Issuer, Senior Officer of Issuer

Executive Director
4,000
4.50
CA$18,000 		4,000 4.50 CA$18,000
2023-07-04 2023-06-30 S Sale
2.2
Athyrium Opportunities II Co-Invest 1 LP

10% Security Holder of Issuer

Large shareholder
1,300,000 -29.9%
5.78
CA$7,507,500 		1,300,000 -29.9% 5.78 CA$7,507,500
2023-06-12 2023-06-08 B Purchase
3.6
Welborn, Jr., John Lee

Director of Issuer

Non-Executive Director
97,000
4.30
CA$417,100 		97,000 4.30 CA$417,100
2023-05-23 2023-05-19 B Purchase
3.4
Hendrickson, Tim

Senior Officer of Issuer

Officer
2,500 +3.8%
4.50
CA$11,250 		2,500 +3.8% 4.50 CA$11,250
Explore more

More insider trading research around HLS Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America